Benefits of Vitamin Supplementation for the Eyes

Back to the About Section


The Age Related Eye Disease Study (AREDS) published in the October 2001 issue of the Archives of Ophthalmology reported the benefit of slowing the progression of macular degeneration in some patients taking large doses of Vitamins A (Lutein), E, C, and the mineral Zinc. The results of the AREDS2 study reported in May of 2013 confirmed the benefits of vitamin supplementation and showed that Lutein was equally as effective as Beta Carotene, but better tolerated. TEBS´┐Ż EYE FORMULA for MACULA SUPPORT 2 is based on this second study.

Antioxidants are also important in supporting the circulatory system, immune system, and many other functions of the body. Antioxidants include: Vitamins A, C, E, bilberry, ginkgo biloba, grape seed extract, zinc, selenium and others. Consuming a diet rich in leafy green vegetables is also a good source of Vitamin A.

Clinical studies have shown the possible reduction in cataract formation with the use if vitamins C and E. In the May 1998 edition of OPHTHALMOLOGY, a study of 764 patients by Dr. Leske concluded that in regular users of multivitamin supplements, the risk of nuclear cataract was reduced by one third; in regular users of Vitamin E supplements the risk was reduced by approximately one half.

Studies of patients with age-related macular degeneration, a progressive retinal disorder that can affect one or both eyes and result in the loss of central vision, have shown the decreased progression of this disease with the increased dietary intake of carotenoids (Vitamin A family) and other antioxidants. In the November 9, 1994 edition of Journal of the American Medical Association, Dr. Seddon found that a higher intake of carotenoids was associated with a lower risk of age-related macular degeneration. The study found that people who consume carotenoids had a statistically significant 43 percent lower risk for age-related macular degeneration compared to those who consumed the lowest. LUTEIN was the carotenoid most strongly associated with the reduced risk of age-related macular degeneration.